NRx Pharmaceuticals Chief Corporate Officer, General Counsel & Corporate Secretary resigns effective July 22, 2022

NRX Pharmaceuticals, Inc.

Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary, effective July 22, 2022.
Resignation not due to any disagreement with management or board regarding operations, policies, or practices.
Ms. Daigneault left to pursue other personal and professional interests.
No successor named in the filing.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Alessandra Daigneault

Chief Corporate Officer, General Counsel and Corporate Secretary

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2022-07-22
Filed: July 28, 2022, 7:59 PM ET

On July 22, 2022, Ms. Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary of NRx Pharmaceuticals, Inc. (the “Company”), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary at NRX Pharmaceuticals, Inc..

Action: resigned
Role: Chief Corporate Officer, General Counsel and Corporate Secretary

Exact text from the filing

On July 22, 2022, Ms. Alessandra Daigneault resigned as Chief Corporate Officer, General Counsel and Corporate Secretary of NRx Pharmaceuticals, Inc. (the “Company”), effective immediately.

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950142-22-002339

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.